Company profile
UK company 09945801, incorporated on 11 January 2016.
Active Needle | Precision targeting of needle placement.
Active Needle Technology Ltd is a UK company with status Active founded in 2016 based in South East England.
Company number 09945801
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUzNzU3MTQ5OWFkaXF6a2N4
Published 07 Aug 2026 16:06
SH01 | Transaction MzUzMTQ3MDg2NWFkaXF6a2N4
Published 09 Jul 2026 11:06
RP01SH01 | Transaction MzUyNzk4NDY3NmFkaXF6a2N4
Published 25 Jun 2026 09:09
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Active Needle Technology is a pre-revenue medical device company exploiting technology developed at the University of Dundee. The company aims to commercialise its award-winning "needle actuating device" technology into a well-segmented $4+ Billion special purpose needle market, especially $1Billion biopsy market, to enable precise needle targeting in ultrasound-guided needle interventional procedures.
Active Needle Technology produces a device for medical procedures involving the insertion of a needle into the patient. It aims to overcome the problem of needle visibility and guidance when using ultrasound, by using ultrasonic vibrations.
ActiveNeedle makes standard needle visible in colour under Doppler ultrasound. Active Needle Technology reduces penetration force and thus tip deflection.
1 Aug 2021 to 30 Nov 2022
This project aims to deliver a revolutionary new, low pain, low trauma tattooing system for the \>$2bn global tattooing market. It builds on a highly successful previous IUK grant which demonstrated proof of concept of ultrasonic low pain tattooing. The innovation is highly novel. There are no other tattoo machine based approaches to reducing pain and ski...
1 Dec 2020 to 30 Nov 2021
Although great progress has been made in the treatment of some common cancers there remain many indications where there has been little improvement in care over decades. The most difficult tumours tend to be inoperable with treatment options limited to chemotherapy and radiotherapy. Chemotherapy is administered systemically and a balance between toxicity ...
1 Apr 2019 to 31 Mar 2020
"Active Needle Technology Limited ""ANT"" are the developers of a novel ultrasound needle ""driver"" technology that exploits the properties of ultrasonic vibration to aid the passage of needles through the tissues of the body. Crucially, the ultrasonic vibration is proven to reduce the needle insertion force and tissue trauma. ANT have developed a medica...
1 Dec 2018 to 30 Nov 2019
"Application defined by a partnership: the lead applicant has an advanced ultrasound ""driven"" needle that greatly improves the accuracy of delivering medicines to deep tissues (improved tissue penetration and highly visible on ultrasound scanners); the partner has a nanotechnology based agent that generates highly localised free radicals to enhance the ...
1 Jan 2018 to 31 Oct 2018
"Active Needle Technology Limited ""ANT"" are the developers of a specialised high frequency vibrating needle that aims to reduce needle placement errors associated with ultrasound guided interventional procedures. This will save time, lower the cost burden on the NHS and other healthcare providers and reduce the need for the patient to return because the...
